Transcripts Astellas Pharma Inc. Deutsche Boerse AG

Equities

Market Closed - Deutsche Boerse AG Other stock markets 03:11:14 2024-05-31 am EDT			5-day change	1st Jan Change
8.808 ^EUR	+0.69%		-1.50%	-19.78%

May. 31	U.S. Food and Drug Administration Acknowledges Astellas Pharma Inc.? Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date	CI
May. 21	Astellas Announces Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies	CI

Transcript : Astellas Pharma Inc., 2024 Earnings Call, Apr 25, 2024	Apr. 25
Transcript : Astellas Pharma Inc. - Special Call	Feb. 20
Transcript : Astellas Pharma Inc., Q3 2024 Earnings Call, Feb 05, 2024	Feb. 05
Transcript : Astellas Pharma Inc. - Special Call	Nov. 05
Transcript : Astellas Pharma Inc., Q2 2024 Earnings Call, Nov 01, 2023	Nov. 01
Transcript : Astellas Pharma Inc., Q1 2024 Earnings Call, Aug 01, 2023	23-08-01
Transcript : Astellas Pharma Inc., IVERIC bio, Inc. - M&A Call	23-04-30
Transcript : Astellas Pharma Inc., 2023 Earnings Call, Apr 27, 2023	23-04-27
Transcript : Astellas Pharma Inc. - Special Call	23-03-27
Transcript : Astellas Pharma Inc. - Special Call	23-02-17
Transcript : Astellas Pharma Inc., Q3 2023 Earnings Call, Feb 06, 2023	23-02-06
Transcript : Astellas Pharma Inc. - Special Call	22-12-08
Transcript : Astellas Pharma Inc., Q2 2023 Earnings Call, Oct 31, 2022	22-10-31
Transcript : Astellas Pharma Inc. - Special Call	22-10-16
Transcript : Astellas Pharma Inc., Q1 2023 Earnings Call, Aug 01, 2022	22-08-01
Transcript : Astellas Pharma Inc., 2022 Earnings Call, Apr 27, 2022	22-04-27
Transcript : Astellas Pharma Inc. - Special Call	22-03-08
Transcript : Astellas Pharma Inc. - Special Call	22-02-28
Transcript : Astellas Pharma Inc., Q3 2022 Earnings Call, Feb 02, 2022	22-02-02
Astellas Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022	22-02-01	CI

No results for this search